pharma · Breast Cancer · Prostate Cancer · UTHR
United Therapeutics Europe
United Therapeutics Europe Ltd
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertensi
Company details
- Status
- Public
- HQ
- 1000 Spring Street, Silver Spring, Maryland 20910, US
- Founded
- 1996
- Employees
- 1,443
- Programs
- 1032
- Drugs
- 612
- Patents
- 3720
Quick answer
United Therapeutics is a pharma organization headquartered in Silver Spring, USA. It trades on NYSE under ticker UTHR. Primary therapeutic focus areas include Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertension, Malaria, HIV Infections. NovaPharmaNews links 1032 clinical program(s), 8 drug profile(s), and 3720 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (336), phase 3 (199), phase 1 (184).
Company snapshot
United Therapeutics Europe maintains 1032 tracked programs across Breast Cancer, Prostate Cancer, Pulmonary Arterial Hypertension, Malaria, HIV Infections, Pulmonary Hypertension, Parkinson Disease, Lung Cancer, Bladder Cancer, Gulf War Illness, COVID-19, Traumatic Brain Injury. Momentum score: 24/100 (30-day delta: n/a). Public registry data covers pipeline phase, clinical trials, patents, SEC fi
- 12 approved product(s) across US/EU regulatory metadata.
- 1032 active pipeline program(s) linked via ClinicalTrials.gov.
- 3720 US patent(s) indexed to this assignee profile.
Public regulatory, clinical, patent, and corporate records for United Therapeutics Europe. Not investment advice.
Recent coverage
Top assets
Lead pipeline drugs
- Marketed / approved
- approved
- approved
- approved
Active clinical programs
- Phase 3
- Phase 3
- Phase 3
- Phase 3
Momentum
Proprietary activity score for United Therapeutics Europe.
2 active signals
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitor landscape
Therapeutic-area overlap peers from registry and pipeline signals.
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
- Peer + 0 momentum
Recent activity
Latest pipeline, patent, and corporate events for United Therapeutics Europe.
- Clinical update
- Clinical update
- Clinical update
- Clinical update
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is United Therapeutics Europe?
-
Is United Therapeutics Europe publicly traded?
-
What drugs does United Therapeutics Europe develop or market?
-
What are the latest developments for United Therapeutics Europe?
-
What therapeutic areas does United Therapeutics Europe focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.